On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
June 13, 2019
Click here for information on the new international export pharmacy permit allowing safe importation of FDA-approved prescription drugs, pending federal approval. Continue reading
June 12, 2019
The Annual Long Range Planning meeting has been scheduled for Friday, October 18, 2019. Please click here for more information. Continue reading